Andon Health Co., Ltd.

Shenzhen Stock Exchange 002432.SZ

Andon Health Co., Ltd. EBIT for the year ending December 31, 2023: USD 224.97 M

Andon Health Co., Ltd. EBIT is USD 224.97 M for the year ending December 31, 2023, a -91.50% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

Andon Health Co., Ltd. EBIT for the year ending December 31, 2022 was USD 2.65 B, a 1,551.84% change year over year.
Andon Health Co., Ltd. EBIT for the year ending December 31, 2021 was USD 160.24 M, a 318.90% change year over year.
Andon Health Co., Ltd. EBIT for the year ending December 31, 2020 was USD 38.25 M, a 819.70% change year over year.
Andon Health Co., Ltd. EBIT for the year ending December 31, 2019 was USD 4.16 M, a 15,209.20% change year over year.

Key data

Date	EBIT	EBITDA	Net Income	EPS (Diluted)

Shenzhen Stock Exchange: 002432.SZ

Andon Health Co., Ltd.

CEO	Mr. Yi Liu
IPO Date	June 10, 2010
Location	China
Headquarters	No. 3 Jinping Road
Employees	1,825
Sector	Health Care
Industries Medical Instruments Hardware & Electronics Pharmaceuticals

Description

Andon Health Co., Ltd. develops, manufactures, and sells health electronics and intelligent hardware products. It offers sphygmomanometers, nebulizers, blood glucose meters, thermometers, fetal heart rate instruments, electrocardiographs, oximeters, smart watches, and body weight scales. The company was founded in 1995 and is based in Tianjin, China.

Key trends

Past 5 years